⌘K
EN
FR
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel) | Government contract · CanPursue
Contracts
active
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel)
Santé Québec Est-de-l’Île-de-Montréal – Universitaire
Novartis Pharma Canada inc.
EA-0659-2024-03
Watch
Total contract value
$22.5M
Original award value
$22.5M
Start
Jan 30, 2025
End
—
Timeline
Official
Awarded
Jan 30, 2025. Original award value: $22.5M